Autonomous Subcutaneous Delivery System

A next-generation subcutaneous delivery tool that leverages advanced materials, artificial intelligence, and modular design to enhance patient safety, reduce healthcare costs, and expand medical applications.

The original subcutaneous delivery tool patent, while innovative, has limitations in terms of biocompatibility, device removal, and customization. The new inventive concept addresses these limitations by incorporating bio-absorbable materials, nanomaterial coatings, artificial intelligence, and modular design to create a more efficient, safe, and adaptable system.

The Autonomous Subcutaneous Delivery System consists of a bio-absorbable implantation device that dissolves within a predetermined timeframe, eliminating the need for device removal. The medical device is coated with a nanomaterial that enhances biocompatibility and reduces inflammation. The system is equipped with artificial intelligence that detects anomalies in patient data and alerts healthcare professionals. The modular design allows for interchangeable components, enabling customization of the device for specific medical applications. Additionally, the system incorporates a miniature energy harvesting system, eliminating the need for battery replacement.

The new claims introduce several novel and non-obvious features, including the use of bio-absorbable materials, nanomaterial coatings, artificial intelligence, and modular design. These advancements significantly improve the safety, efficiency, and adaptability of the subcutaneous delivery tool, making it a paradigm-shifting innovation in the field.

Alternative embodiments of the Autonomous Subcutaneous Delivery System could include variations in the bio-absorbable material composition, nanomaterial coating thickness, artificial intelligence algorithms, and modular component designs. Additionally, the system could be adapted for use in different medical applications, such as diabetes management or cardiovascular disease monitoring.

The Autonomous Subcutaneous Delivery System has significant commercial potential in the medical device industry, with potential applications in chronic disease management, patient monitoring, and personalized medicine. The market for this technology is vast, with potential customers including hospitals, clinics, and pharmaceutical companies.